---
title: "SEDA PHARMA DEVELOPMENT SERVICES LTD. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/39f3baf2-830d-5e4e-9704-892227c5ded8
json: https://whiteintel.dev/api/public/dossier/39f3baf2-830d-5e4e-9704-892227c5ded8
identifier: oo:GB-COH-09442533
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SEDA PHARMA DEVELOPMENT SERVICES LTD.

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-09442533`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/39f3baf2-830d-5e4e-9704-892227c5ded8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/39f3baf2-830d-5e4e-9704-892227c5ded8  

## Ownership & control

### Owners / controllers

- **Mr Marcel De Matas** (beneficial owner) — 50% — https://whiteintel.dev/entity/eab425e8-9386-5ee3-98d5-41e7fddbfd03
- **Mr Paul Alfred Dickinson** (beneficial owner) — 50% — https://whiteintel.dev/entity/5098f081-7514-5fac-87dd-8555acb519cf
- **Mr Paul Alfred Dickinson** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/737b741d-ec47-4df2-8e27-8f2056e46369
- **Mr Marcel De Matas** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/20e85a48-f1c6-4c05-b166-28ecdb55ae01
- **Mr Paul William Stott** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/2621885a-6a35-4377-85d6-dceb7c7219ef
- **BGF NOMINEES LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/4fc35eb4-3b89-52e9-9fc9-2ce07d736869
- **ALEVA HOLDINGS LIMITED** (beneficial owner) — https://whiteintel.dev/entity/51547997-d114-4a3f-ac1c-148a7c4a390f

### UBO chain (walk to the ultimate owner)

A **71-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `09442533`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2015-02-17
- **Registered office:** Unit 4 Oakfield Road Cheadle Royal Business Park, Cheadle, Stockport, Greater Manchester, SK8 3GX, England
- **SIC:** 72190

### Officers

- ANDREW, Jonathan Charles — director · British · appointed 2026-03-16
- DE MATAS, Marcel — director · British · appointed 2015-02-17
- DICKINSON, Paul Alfred — director · British · appointed 2015-02-17
- JONES, Harry Robert James — director · British · appointed 2026-03-16
- STOTT, Paul William — director · British · appointed 2019-04-24

### Beneficial owners (Persons with Significant Control)

- [Bgf Nominees Limited](https://whiteintel.dev/entity/4fc35eb4-3b89-52e9-9fc9-2ce07d736869) — 25–50% shares · corporate PSC · England — since 2026-03-16
- Mr Paul William Stott — 25–50% shares · individual PSC · England — ceased 2026-03-16
- [Aleva Holdings Limited](https://whiteintel.dev/entity/51547997-d114-4a3f-ac1c-148a7c4a390f) — 25–50% votes · corporate PSC · United Kingdom — ceased 2026-03-03
- Mr Marcel De Matas — 25–50% shares · individual PSC · England — ceased 2026-03-16
- Mr Paul Alfred Dickinson — 25–50% shares · individual PSC · England — ceased 2026-03-16

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09442533
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/09442533

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SEDA PHARMA DEVELOPMENT SERVICES LTD.**. Human view: https://whiteintel.dev/entity/39f3baf2-830d-5e4e-9704-892227c5ded8 · Structured JSON: https://whiteintel.dev/api/public/dossier/39f3baf2-830d-5e4e-9704-892227c5ded8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._